Niagen® nicotinamide riboside, the nutrient that supports cellular energy
As we age, our cells gradually lose their ability to produce energy efficiently. Patent-protected Niagen® is changing the way we address aging at the cellular level, and contributes to the growing science behind NAD+. Here's what you need to know about NAD+, why NR is the superior precursor, and why Niagen® is the science-backed gold standard.
Nicotinamide riboside: A scientifically validated NAD+ precursor
In 2004, Dr. Charles Brenner’s research identified nicotinamide riboside as an effective precursor to NAD+, revealing new pathways for cellular NAD+ biosynthesis. His groundbreaking findings showed that this naturally occurring compound effectively crosses cellular membranes and converts to bioavailable NAD+, offering advantages over direct NAD+ supplementation.

“14 years and 40 published studies on Niagen® NR later, its unique ability to restore balance in the face of metabolic stress continues to amaze me.”
Charles Brenner, Ph.D., Niagen Bioscience’s Chief Scientific Advisor | Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism at City of Hope
The scientist who discovered nicotinamide riboside's utility as a micronutrient
Backed by 25 years of research & innovation
We've led the way in healthy aging science, pioneering discoveries in NAD+ with Niagen®.
Regulatory recognition and third-party testing confirms safety and quality
Niagen® has received approval from leading regulatory agencies worldwide, such as Brazil's ANVISA, the European Commission, Australia's TGA, and Health Canada as a Natural Health Product. Niagen is the only NR product that has been notified to the FDA as GRAS and a New Dietary Ingredient.

Clinical research provides the scientific foundation
More than 35 clinical studies support Niagen®'s safety and efficacy, with over 65% of registered nicotinamide riboside trials utilizing this patented ingredient. These peer-reviewed, published studies form the evidence base supporting every Tru Niagen capsule.
Blog posts

The Double Action of Niagen®: Boosting NAD+ While Inhibiting CD38
An exciting preclinical study uncovers a new physiological role of NR related to the enzyme CD38. Overexpression of CD38 degrades NAD+, contributing to low NAD+ levels. This study finds that...

Recent Report Reveals 76% of NAD+ Supplements Fail to Meet Label Claims
Niagen Bioscience's latest analysis reveals that 76% of NAD+ supplements on Amazon fail to meet label claims, with more than half containing virtually no NAD+ at all. This comprehensive testing...

The Myth of Liposomal NAD+: Why Science Favors NR Supplementation with Tru Niagen
Discover why liposomal NAD+ supplements fail to deliver on their promises and how scientifically validated Nicotinamide Riboside (NR) effectively supports your cellular health with proven results.

New ChromaDex Study Finds 87% of Nicotinamide Riboside (NR) Supplements Fail to Meet Label Claims
A new ChromaDex study finds only 13% of NR supplements meet label claims. Learn which brands passed testing and why liposomal formulas struggle with potency.
Award-winning, clinically proven NAD+ boosters
Discover the right Tru Niagen product for you.